Get informed when a big investor buys or sells
+ Follow39.34%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for RTW.L is 39.34%. That is above the sector sector average of 10.27%. Investors often review this figure alongside RTW Biotech Opportunities Ltd USD's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, RTW.L currently prints 39.34% for ROE, while the sector average sits near 10.27%. That is roughly 283.3% above the sector mean. Large gaps often invite a closer look at RTW Biotech Opportunities Ltd USD's growth, margins, and balance sheet.
Return on Equity shows how effectively RTW Biotech Opportunities Ltd USD converts resources into returns. At 39.34%, RTW.L may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting RTW.L's ROE (39.34%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.